Trump’s Tariff Rollercoaster Keeps Pharma On Edge

The rollout of Trump’s tariff plan has been a policy whiplash, but despite a 90-day pause on tariffs, it appears the US president is still holding a grudge with industry over drug pricing.

(Shutterstock)

More from Manufacturing

More from Strategy